Some studies (like a recent one tracking over 18,000 adults)suggest that tirzepatide (used in Mounjaro and Zepbound), may lead to slightly more weight loss on average than semaglutide (in Wegovy, Ozempic, and Rybelsus)
SeekPeptides emphasizes evidence-based approaches precisely because the peptide research community values scientific validation
Highly professional and knowledgeable
Patients can access FDA-approved branded medications, including both injectable and oral GLP-1 options, through simple telehealth visits
This article is provided for informational context regarding published preclinical research findings and general analytical considerations, and does not constitute medical, clinical, veterinary guidance or treatment advice.
FDA approved medication In clinical studies patients showed an average loss of 35 pounds or 15% of bodyweight used in combination with diet and exercise